美国食品药品监督管理局 (FDA) 已授予 PYX-201 快速通道资格，这是一种首创抗体药物偶联物 (ADC)，用于治疗在接受铂类化疗和抗 PD- (L)1 抗体治疗后病情出现进展的 R/M HNSCC 成年患者。

Inc.'s eighth annual Female Founders list highlights the nation's top business leaders who challenge the status quo to tackle some of the world's biggest problems Pyx Health is proud to share that ...

PYX Resources Ltd - Indonesia-focused zircon and mineral sands producer - Pretax loss narrows to USD4.1 million in 2024 from GBP10.5 million in 2023. This is driven by total expenses being reduced by ...

Recently reported positive preliminary data from Phase 1 dose escalation trial of micvotabart pelidotin (“MICVO,” formerly PYX-201), including ...

The US Food and Drug Administration (FDA) has granted fast track designation to Pyxis Oncology’s antibody-drug conjugate (ADC), PYX-201, to treat adults with recurrent or metastatic head and neck ...

The FDA has granted PYX-201 fast track designation for treatment of recurrent or metastatic HNSCC after progression post-chemoimmunotherapy. PYX-201 received FDA fast track designation for use in ...

If you want a top-notch laptop with serious gaming chops, then you need to jump on this HP Omen 17 deal at B&H. It normally ...

THE trial of the Pyx is the formal testing of the coin of the realm, to ensure its being of the requisite weight and fineness. The name is derived from the Pyx, or chest, in which the coins ...

BOSTON, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that the ...

Having recently trimmed back its pipeline to a sole cancer candidate, Pyxis Oncology has now reduced its head count to match. | Having recently trimmed back its pipeline to a sole cancer candidate, ...